COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults - Impact of Variants (Dyn3CEA

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

87 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-06-22

Study Completion Date

2021-10-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Unlike other respiratory viruses such as influenza and RSV where the child is the essential reservoir and central vector of intrafamilial contamination, the child is likely to be a small player in the transmission of CoV2-CoRSA infection. This study aims to describe the age category of the first contact, within 14 days before the appearance of the first symptoms of the index case in order to describe the age categories of this first contaminant, globally, in the group of children and finally in the group of adults. This work is intended to provide food for discussion and to justify the distancing and containment measures imposed on children when their isolation has a deleterious impact that has now been established for some children.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

COVID-19 - SARS-CoV-2 Community Contamination in Children and Adults (Dyn3CEA_Nosocor)

NCT04664296

Infection Viral

COMPLETED

Outcomes in Hospitalized Older Patients With COVID-19

NCT04385212

Coronavirus Infection Sars-CoV2 Elderly Infection +1 more

COMPLETED

STUDY OF THE COVID-19 EPIDEMIC AND SOCIO-ECONOMIC LIVING CONDITIONS IN FRANCE

NCT05336604

General Population

COMPLETED

Host-pathogen Interactions During SARS-CoV-2 Infection

NCT04376476

Infection, Coronavirus Severe Acute Respiratory Syndrome Coronavirus 2

COMPLETED NA

Measure of Vaccine Effectiveness to Prevent Hospitalizations for Viral Respiratory Infections in Adults

NCT05582239

Severe Acute Respiratory Infection (SARI) Influenza COVID-19

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infection Viral

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Children

Hospitalized children, 0 to 17 years of age, 30 subjects, consecutive sample survey, recruitment in quotas of five age ranges.

Review of medical file

Intervention Type OTHER

Review of medical patient file, including patient tracing, brief summary of the disease course, barrier gestures, social distancing.

Adults

Hospitalized adults, 18 years and above, 60 matched subjects

Phone call interview

Intervention Type OTHER

less than 15 minutes phone call

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Review of medical file

Review of medical patient file, including patient tracing, brief summary of the disease course, barrier gestures, social distancing.

Intervention Type OTHER

Phone call interview

less than 15 minutes phone call

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1\) Children hospitalized in the Pediatric department of the Hospices Civils de Lyon with PCR positive for a variant of the historical SARS-CoV2, 2) Adults hospitalized in the the Hospices Civils de Lyon, for a Covid-19 disease with documented infection by a variant of the SARS-CoV-2 and included in the NOSO-COR study with matching criteria described below.

Exclusion Criteria

1. Any patient suspected of nosocomial infection.
2. Any patient death during the Covid-19 infection.
3. Any adult patient without children living home.
4. Opposition to participate.

Eligible Sex

ALL

Accepts Healthy Volunteers

No